AKT1 and breast cancer: Additionally, baseline somatic mutations in 2 key BC-related signaling pathways, the phosphatidylinositol-3-kinase-AKT (PI3K-AKT) pathway and the homologous recombinational repair (HRR) pathway, were more likely to be observed in patients not achieving pCR (Figure 2).